Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Corti

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Plos One|June 4, 2015
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityLorenzo Di Cesare Mannelli, Alessandra Pacini, Francesca Corti, et al.
Breast Cancer Research : BCR|April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implicationsClaudio Vernieri, Francesca Corti, Federico Nichetti, et al.
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Frontiers in Plant Science|September 11, 2023
Comparative analysis of wild-type and chloroplast MCU-deficient plants reveals multiple consequences of chloroplast calcium handling under drought stressFrancesca Corti, Margherita Festa, Frank Stein, et al.
Neuropharmacology|December 16, 2017
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulationLorenzo Di Cesare Mannelli, Barbara Tenci, Laura Micheli, et al.
Cancers|June 19, 2024
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future PerspectivesFrancesca Corti, Roberta Elisa Rossi, Pietro Cafaro, et al.
Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
Oncology Research and Treatment|March 6, 2019
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective AnalysisGiulia Galli, Stefano Cavalieri, Lorenza Di Guardo, et al.
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Plos One|June 4, 2015
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityLorenzo Di Cesare Mannelli, Alessandra Pacini, Francesca Corti, et al.
Breast Cancer Research : BCR|April 8, 2020
Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implicationsClaudio Vernieri, Francesca Corti, Federico Nichetti, et al.
Tumori|October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trialFilippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Frontiers in Plant Science|September 11, 2023
Comparative analysis of wild-type and chloroplast MCU-deficient plants reveals multiple consequences of chloroplast calcium handling under drought stressFrancesca Corti, Margherita Festa, Frank Stein, et al.
Neuropharmacology|December 16, 2017
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulationLorenzo Di Cesare Mannelli, Barbara Tenci, Laura Micheli, et al.
Cancers|June 19, 2024
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future PerspectivesFrancesca Corti, Roberta Elisa Rossi, Pietro Cafaro, et al.
Tumori|May 2, 2018
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledgeSara Pusceddu, Natalie Prinzi, Alessandra Raimondi, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
Oncology Research and Treatment|March 6, 2019
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective AnalysisGiulia Galli, Stefano Cavalieri, Lorenza Di Guardo, et al.
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.
Pageof 7